Release date: 7/31/24
Expiration date: 7/30/26
Estimated Time of Completion: 3 hours and 45 minutes
Session Agenda
Update in Treatment of Advanced Non-Melanoma Skin Cancers
Alok Vij, MD, Cleveland Clinic
Update in Treatment of Cutaneous irAEs Related to Cancer Immunotherapies
Laura Korb Ferris, MD, PhD, University of Pittsburgh
Update in Treatment of Cutaneous T-cell Lymphomas
Joan Guitart, MD, Northwestern University Feinberg School of Medicine
Update in Treatment of Autoimmune Bullous Diseases
Neil Korman, MD, PhD, UH Cleveland Medical Center
Update in Treatment of Sarcoidosis and Granulomatous Diseases
Christine Warren, MD, Cleveland Clinic
Artificial Intelligence in Medical Dermatology *
James Taylor, MD, Cleveland Clinic
Description
Watch Medical Dermatology Therapy Update Webcast Series, recorded from Medical Dermatology Therapy Update III: Autoimmune, Chronic Inflammatory, and Advanced Malignant Diseases.
This CE-certified educational series offers a unique opportunity to update your knowledge and understanding of both traditional and new therapeutic strategies for a range of critically important medical dermatologic conditions, including rheumatology-dermatology overlap diseases, atopic dermatitis, advanced melanoma and other cutaneous malignancies, urticaria, sarcoidosis, hidradenitis suppurativa, autoimmune bullous disease, cutaneous lymphomas, alopecia areata, and psoriatic disease.
Learning Objectives
- Review classes and mechanisms of action of commonly used immune check point inhibitors (ICI).
- Discuss potential mechanisms of induction of cutaneous immune related adverse events (cir-AEs) in patients on ICI.
- Review common and uncommon cir-AEs and their treatments.
- Briefly describe current understanding of the pathophysiology of select non-infectious cutaneous granulomatous diseases, including sarcoidosis, granuloma annulare, and necrobiosis lipoidica.
- Highlight systemic comorbidities and interdisciplinary care coordination.
- Review current and emerging therapies in these skin diseases.
- Highlight an overview of artificial intelligence (AI), focusing on dermatology applications.
- Identify Chat GPT’s use in healthcare and medical diagnosis.
- Discuss AI regulations and future implications.
Target Audience
The online series is designed for physicians, pharmacists, nurses, advanced practice clinicians, physician assistants, residents, fellows and allied health professionals in dermatology, immunology, oncology, rheumatology, internal medicine, family medicine, and general practice.
Accreditation
In support of improving patient care, Cleveland Clinic Center for Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians / American Medical Association (AMA)
Cleveland Clinic Foundation Center for Continuing Education designates this internet enduring activity for a maximum of 3.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.
Nurses / American Nurses Credentialing Center (ANCC)
Cleveland Clinic Center for Continuing Education designates this internet enduring activity for a maximum of 3.75 ANCC contact hours.
Physician Assistants / American Academy of PAs (AAPA)
Cleveland Clinic Center for Continuing Education has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 3.75 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Accreditation Council of Pharmacy Education (ACPE)
Cleveland Clinic Center for Continuing Education designates this knowledge-based activity for a maximum of 3.75 hours. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion.
Universal Activity Number List:
JA0000192-0000-24-549-H01-P
JA0000192-0000-24-549-H01-T
Certificate of Participation
A certificate of participation will be provided to other health care professionals for requesting credits in accordance with their professional boards and/or associations.
Activity Director and Faculty
Activity Director
Anthony P. Fernandez, MD, PhD
Director of Medical Dermatology
Department of Dermatology
Cleveland Clinic
Cleveland, OH
Planning Committee
Madeline June, CNP
Department of Dermatology
Cleveland Clinic
Cleveland, OH
Sean Krohn, PharmD
Specialty Pharmacy
Cleveland Clinic
Cleveland, OH
Jessica Wampleman, RN
Department of Dermatology
Cleveland Clinic
Cleveland, OH
Clara Wilson, PA-C
Department of Dermatology
Cleveland Clinic
Cleveland, OH
Faculty
Alok Vij, MD
Section Head - Teledermatology
Department of Dermatology
Associate Professor of Dermatology
Cleveland Clinic Lerner College of Medicine
Cleveland Clinic
Cleveland, OH
Joan Guitart, MD
Chief, Dermapathology
Department of Dermatology
Northwestern University
Feinberg School of Medicine
Chicago, IL
Laura Korb Ferris, MD, PhD
Department of Dermatology
Cleveland Clinic
Cleveland, OH
Neil Korman, MD, PhD
Director, Murdough Family Center for Psoriasis
UH Cleveland Medical Center
Cleveland, OH
Christine Warren, MD
Department of Dermatology
Cleveland Clinic
Cleveland, OH
James Taylor, MD
Department of Dermatology
Cleveland Clinic
Cleveland, OH
CME Disclaimer
The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.
Disclosures
In accordance with the Standards for Integrity and Independence issued by the Accreditation Council for Continuing Medical Education (ACCME), Cleveland Clinic Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty have indicated that they may have a relationship, which in the context of their presentation(s), could be perceived as a potential conflict of interest:
| Anthony P. Fernandez, MD, PhD |
|
Boehringer Ingelheim
UCB, Inc. |
Consulting |
Bristol-Myers Squibb Co.
Novartis
Mallinckrodt Inc.
Biogen Inc. |
Consulting
Teaching and Speaking |
Pfizer, Inc. |
Other activities from which remuneration is received or expected: awarded a grant to fund a medical dermatology fellowship position
Research: PI |
Abbvie Pharmaceuticals |
Consulting
Advisor or review panel participant
Teaching and Speaking |
Kyowa Kirin |
Teaching and Speaking |
| Laura Korb Ferris, MD |
|
Eli Lilly, Castle Biosciences |
Research: PI |
Novartis |
Consulting |
BMS |
Consulting
Teaching and Speaking
Research: sub investigator |
Amgen, DermTech Inc., Sanofi Regeneron, Takeda Pharmaceutical Ltd, Janssen Pharmaceuticals, Inc. |
Consulting
Research: PI |
Arcutis |
Consulting
Teaching and Speaking |
Abbvie Pharmaceuticals |
Consulting
Teaching and Speaking
Research: PI |
| Joan Guitart, MD |
|
Kyowa Hakko Kirin Co. Ltd.
Castle Biosciences |
Consulting |
| Neil Korman, MD |
|
Astra Zeneca
ArgenX |
Consulting |
Eli Lilly |
Consulting
Other activities from which remuneration is received or expected: Research
Teaching and Speaking |
Novartis
Regeneron |
Consulting
Research & Teaching |
Janssen |
Consulting
Advisor or review panel participant
Teaching and Speaking |
LEO |
Other activities from which remuneration is received or expected: Research |
AbbVie Pharmaceuticals |
Consulting
Advisor or review panel participant
Other activities from which remuneration is received or expected: Research
Teaching and Speaking |
| James S. Taylor, MD |
|
Astra Zeneca
Johnson & Johnson
Merck & Co, Inc.
Cigna
Opko Health |
Ownership interest (stock, stock options in a publicly owned company) |
Kao Brands |
Consulting |
| Alok Vij, MD |
|
MiMedx |
Consulting
Teaching and Speaking
Research: Investigator initiated trial |
The following faculty have indicated they have no relationship which, in the context of their presentation(s), could be perceived as a potential conflict of interest:
Madeline June, CNP
Sean Krohn, PharmD
Jessica Wampleman, RN
Christine Warren, MD
Clara Wilson, PA-C
Acknowledgment
The Cleveland Clinic Foundation Center for Continuing Education acknowledges educational grants for partial support of this activity from:
Janssen Scientific Affairs, LLC
Novartis Pharmaceuticals Corporation
Sun Pharmaceutical Industries, Inc.
This CME activity was produced by the Cleveland Clinic Foundation Center for Continuing Education, Cleveland Clinic’s Department of Dermatology.
